Genetic modifiers of airway infection by nontuberculous mycobacteria in people with cystic fibrosis
RATIONALE: Persistent lung infection by nontuberculous mycobacteria (NTM) is a prerequisite for progression to NTM pulmonary disease, a serious clinical outcome for people with cystic fibrosis (PwCF). Understanding risk factors for persistent infection will improve patient care. OBJECTIVES: We sought to identify genomic loci associated with persistent lung infection by Mycobacterium avium and Mycobacterium abscessus complexes in PwCF. METHODS: We performed genome-wide association studies of persistent NTM infection in PwCF enrolled in the CF Genome Project, as well as several secondary studies to assess test sensitivity. Persistent NTM airway infection was defined as two positive sputum cultures within three years, and two NTM species complexes were independently tested as primary outcomes. MEASUREMENTS: The primary genome-wide association study included whole genome sequencing data for 2,068 participants with NTM culture data who met demographic inclusion criteria. Persistent infection by Mycobacterium avium complex and Mycobacterium abscessus complex were the primary outcomes of study. MAIN RESULTS: A significant association signal was observed for each primary outcome. The genotype of a locus near ICOS (p = 8.48 x 10-9) was associated with persistent Mycobacterium avium complex infection, while the genotype of a locus overlapping ASB13 (p = 2.19 x 10-9) was associated with persistent Mycobacterium abscessus infection. CONCLUSIONS: The detection of associations between specific genomic loci and persistent NTM airway infections allows for better assessment of individual risk in PwCF, guides surveillance intensity, provides clues regarding underlying biology of infection, and identifies pathways that may be targeted by therapeutics.
Authors
- Elizabeth Blue (ORCID: https://orcid.org/0000-0002-0633-0305)
- Karen S. Raraigh (ORCID: https://orcid.org/0000-0001-6730-6854)
- Ronald L. Gibson
- Joseph Michael Collaco (ORCID: https://orcid.org/0000-0002-2581-4372)
- Anna Faino (ORCID: https://orcid.org/0000-0001-9427-9548)
- Rhonda G. Pace (ORCID: https://orcid.org/0000-0001-8606-0327)
- Hong Dang (ORCID: https://orcid.org/0000-0002-7305-4208)
- William W. Gordon (ORCID: https://orcid.org/0000-0003-1334-4235)
- Wanda K. O’Neal (ORCID: https://orcid.org/0000-0003-2412-5943)
- Michael R. Knowles (ORCID: https://orcid.org/0000-0002-4672-5969)
- Michael J. Bamshad (ORCID: https://orcid.org/0000-0002-9647-0861)
- Kati J. Buckingham (ORCID: https://orcid.org/0009-0003-0627-0554)
- Garry R. Cutting (ORCID: https://orcid.org/0000-0002-8250-8590)
- Adrienne M. Stilp (ORCID: https://orcid.org/0000-0002-3910-0776)
- Yi-Hui Zhou
Institutions
- University of North Carolina at Chapel Hill (US)
- North Carolina State University (US)
- Johns Hopkins University (US)
- University of Washington (US)
- Johns Hopkins Medicine (US)
- University of Washington Medical Center (US)
- Seattle Children's Hospital (US)
- Brotman Baty Institute (US)
- Seattle Children's Research Institute (US)
Publication Details
- Journal
- Annals of the American Thoracic Society
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/annalsats/aaoag354
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00